Effectiveness of β-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?

British Journal of Clinical Pharmacology

Volumn 63, Issue 3, 2007, Pages 356-364

  Dobre, Daniela ^a   DeJongste, Mike J L ^b   Lucas, Carolien ^c   Cleuren, Ger ^c   Van Veldhuisen, Dirk J ^b   Ranchor, Adelita V ^a   Haaijer Ruskamp, Flora ^a,b  

^a Northern Centre for Healthcare Research   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RIJNLAND HOSPITAL   (Netherlands)

Author keywords

blockers; Advanced chronic heart failure; Daily practice; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; COUMARIN DERIVATIVE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; FUROSEMIDE; LABETALOL; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NEBIVOLOL; NITRIC ACID DERIVATIVE; PERINDOPRIL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIOLOGY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; SURVIVAL RATE;

EID: 33846970911     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02769.x     Document Type: Article

References (32)

1. Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995; 92: 1499-506.
2. Goldstein S, Fagerberg B, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study. J Am Coll Cardiol 2001; 38: 932-8.
3. Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 2003; 289: 712-8.
4. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162: 1682-8.
5. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet 2003; 362: 147-58.
6. Pernenkil R, Vinson JM, Shah AS, Beckham V, Wittenberg C, Rich MW. Course and prognosis in patients > or =70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997; 79: 216-9.
7. Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 2002; 113: 650-6.
8. Baxter AJ, Spensley A, Hildreth A, Karimova G, O'Connell JE, Gray CS. Beta blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 2002; 88: 611-4.
9. Flather MD, Shibata MC, Coats AJS, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Bohm M, Anker SD, Thompson SG, Poole-Wilson PA. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215-25.
10. Kerzner R, Gage BF, Freedland KE, Rich MW. Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J 2003; 146: 286-90.
11. Johnson D, Jin Y, Quan H, Cujec B. Beta-blockers and angiotensin- converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 2003; 42: 1438-45.
12. Lenzen MJ, Scholte Op Reimer WJ, Boersma E, Vantrimpont PJMJ, Follath F, Swedberg K, Cleland J, Komajda M. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004; 25: 1214-20.
13. Robertshaw M, Lai KN, Swaminathan R. Prediction of creatinine clearance from plasma creatinine - comparison of 5 formulas. Br J Clin Pharmacol 1989; 28: 275-80.
14. Joffe MM, Rosenbaum PR. Invited commentary: Propensity scores. Am J Epidemiol 1999; 150: 327-33.
15. Wikstrand J, Hjalmarson A, Waagstein F, Fagerberg B, Goldstein S, Kjekshus J, Wedel H and MERIT-HF Study Group. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure - analysis of the experience in Metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol 2002; 40: 491-8.
16. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-50.
17. Zi M, Wisniacki N, Delaney J, Donnellan C, Lye M. Autonomic function in elderly patients with chronic heart failure. Eur J Heart Fail 2002; 4: 605-11.
18. Kitzman DW. Diastolic heart failure in the elderly. Heart Fail Rev 2002; 7: 17-27.
19. Benedict CR, Weiner DH, Johnstone DE, Bourassa MG, Ghali JK, Nicklas J, Kirlin P, Greenberg B, Quinones MA, Yusuf S. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction - results of the Studies of Left-Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators. J Am Coll Cardiol 1993; 22: A146-A153.
20. Foody JM, Farrell MH, Krumholz HM. Beta-blocker therapy in heart failure - scientific review. JAMA 2002; 287: 883-9.
21. Gheorghiade M, Colucci WS, Swedberg K. Beta-blockers in chronic heart failure. Circulation 2003; 107: 1570-5.
22. Nodari S, Metra M, Cas LD. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. Eur J Heart Fail 2003; 5: 621-7.
23. Raza JA, Movahed A. Use of cardiovascular medications in the elderly. Int J Cardiol 2002; 85: 203-15.
24. Lamy PP. Issues in prescription drugs and the elderly. Health Affairs 1991; 10: 228-9.
25. Lamy PP. Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy. Drugs Aging 1991; 1: 385-404.
26. Dulin BR, Haas SJ, Abraham WT, Krum H. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of > 12,000 patients in large-scale clinical trials. Am J Cardiol 2005; 95: 896-8.
27. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103: 1428-33.
28. Fung JW, Chan SK, Yeung LY, Sanderson JE. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials. Eur J Heart Fail 2002; 4: 489-94.
29. Singh A, Blackwell J. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction? J Fam Pract 2005; 54: 370-1.
30. van Kraaij DJW, Jansen RWMM, Sweep FCGJ, Hoefnagels WHL. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. Eur J Heart Fail 2003; 5: 47-53.
31. Butler J, Arbogast PG, Belue R, Daugherty J, Jain MK, Ray WA, Griffin MR. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol 2002; 40: 1589-95.
32. Butler J, Arbogast PG, Daugherty J, Jain MK, Ray WA, Griffin MR. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 2004; 43: 2036-43.